All latent EBV antigen specific CD8+ and many CD4+ T cells directly recognize LCLs and can kill them, suggesting protective functions against EBV infection and its pathologies in vivo [51,52,53]. The gene discussed is CD8A; the disease is Epstein-Barr virus infection.